A new noninvasive technology, called broadband optical spectroscopy (BOS), has promise to reliably detect necrotizing ...
Agreement with Nestlé Health Science provides $25 million payable to Seres in 2026 as a buy-out of potential future VOWST™ net sales-based ...
“Taking something that would bring us liabilities for the next 20 years is not something I will do for the company” – CEO ...
Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced the publication of new research on probiotic use and necrotizing enterocolitis (NEC) in preterm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results